Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kubeczko, Marcin, Tudrej, Patrycja, Tyszkiewicz, Tomasz, Krzywon, Aleksandra, Oczko-Wojcechowska, Malgorzata, Jarząb, Michał
Format: Recurso digital
Sprache:
Veröffentlicht: Zenodo 2024
Online-Zugang:https://doi.org/10.5281/zenodo.16410093
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866902289243963392
author Kubeczko, Marcin
Tudrej, Patrycja
Tyszkiewicz, Tomasz
Krzywon, Aleksandra
Oczko-Wojcechowska, Malgorzata
Jarząb, Michał
author_facet Kubeczko, Marcin
Tudrej, Patrycja
Tyszkiewicz, Tomasz
Krzywon, Aleksandra
Oczko-Wojcechowska, Malgorzata
Jarząb, Michał
contents <p><span lang="EN-US">The Figure was published in the Oncology Letters, Funding sources: National Science Centre, Poland (project No. 2021/05/X/NZ5/00971)  [Narodowe Centrum Nauki]</span></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_16410093
institution Zenodo
language
publishDate 2024
publisher Zenodo
record_format zenodo
spellingShingle Figure 3. miRNA expression in patients with progressive disease (group 1) compared with patients with clinical benefit (stable disease + partial response + complete response; group 2). Statistically significant miR expression levels of (A) miR-200b, (B) miR-34a, (C) miR-21, (D) miR-200a and (E) miR-193b. miR, microRNA.
Kubeczko, Marcin
Tudrej, Patrycja
Tyszkiewicz, Tomasz
Krzywon, Aleksandra
Oczko-Wojcechowska, Malgorzata
Jarząb, Michał
<p><span lang="EN-US">The Figure was published in the Oncology Letters, Funding sources: National Science Centre, Poland (project No. 2021/05/X/NZ5/00971)  [Narodowe Centrum Nauki]</span></p>
title Figure 3. miRNA expression in patients with progressive disease (group 1) compared with patients with clinical benefit (stable disease + partial response + complete response; group 2). Statistically significant miR expression levels of (A) miR-200b, (B) miR-34a, (C) miR-21, (D) miR-200a and (E) miR-193b. miR, microRNA.
url https://doi.org/10.5281/zenodo.16410093